Tonnel, A B <br/><br/>
Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.  [electronic resource] 

 -  Respiratory medicine  Jun 2000 
 - S29-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-6111 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adolescent<br/>Adult<br/>Aerosol Propellants--adverse effects<br/>Aged<br/>Aged, 80 and over<br/>Androstadienes--administration & dosage<br/>Anti-Asthmatic Agents--administration & dosage<br/>Asthma--drug therapy<br/>Chlorofluorocarbons--adverse effects<br/>Double-Blind Method<br/>Female<br/>Fluticasone<br/>Forced Expiratory Volume--physiology<br/>Humans<br/>Hydrocarbons, Fluorinated--adverse effects<br/>Hydrocortisone--blood<br/>Male<br/>Middle Aged<br/>Peak Expiratory Flow Rate--physiology<br/>Therapeutic Equivalency<br/>Treatment Outcome